Full View

Cost-effectiveness of transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at intermediate risk: results from the PARTNER 2 …

SJ Baron, K Wang, JA House, EA Magnuson… - Circulation, 2019 - Am Heart Assoc
Background: In patients with severe aortic stenosis (AS) at intermediate surgical risk,
treatment with transcatheter aortic valve replacement (TAVR) or surgical aortic valve …
被引用次数：163 相关文章

Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Risk.

SJ Baron, K Wang, JA House, EA Magnuson… - Circulation, 2019 - europepmc.org
Background In patients with severe aortic stenosis (AS) at intermediate surgical risk,
treatment with transcatheter aortic valve replacement (TAVR) or surgical aortic valve …

Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Risk

SJ Baron, K Wang, JA House, EA Magnuson… - Circulation, 2019 - Am Heart Assoc
BACKGROUND: In patients with severe aortic stenosis (AS) at intermediate surgical risk,
treatment with transcatheter aortic valve replacement (TAVR) or surgical aortic valve …

Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Risk

SJ Baron, K Wang, JA House, EA Magnuson… - Circulation, 2019 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Background:</jats: title>< jats: p> In patients with severe aortic
stenosis (AS) at intermediate surgical risk, treatment with transcatheter aortic valve …

Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Risk

SJ Baron, K Wang, JA House, EA Magnuson… - 2019 - pubmed.ncbi.nlm.nih.gov
Background In patients with severe aortic stenosis (AS) at intermediate surgical risk,
treatment with transcatheter aortic valve replacement (TAVR) or surgical aortic valve …